C16-PAF
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


C16-PAF
Description :
C16-PAF (PAF (C16) ), a phospholipid mediator, is a platelet-activating factor and ligand for PAF G-protein-coupled receptor (PAFR) . C16-PAF exhibits anti-apoptotic effect and inhibits caspase-dependent death by activating the PAFR. C16-PAF is a potent MAPK and MEK/ERK activator. C16-PAF induces increased vascular permeability[1][2][3][4][5].Product Name Alternative :
PAF (C16)UNSPSC :
12352211Target :
Endogenous Metabolite; ERK; MEK; p38 MAPKType :
Reference compoundRelated Pathways :
MAPK/ERK Pathway; Metabolic Enzyme/Protease; Stem Cell/WntApplications :
Metabolism-protein/nucleotide metabolismField of Research :
Inflammation/Immunology; Cardiovascular DiseaseAssay Protocol :
https://www.medchemexpress.com/c16-paf.htmlPurity :
99.86Solubility :
DMSO : 100 mg/mL (ultrasonic)Smiles :
CCCCCCCCCCCCCCCCOC[C@@H](OC(C)=O)COP(OCC[N+](C)(C)C)([O-])=OMolecular Formula :
C26H54NO7PMolecular Weight :
523.68References & Citations :
[1]Scott D Ryan, et al. Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons. J Lipid Res. 2008 Oct;49 (10) :2250-8.|[2]Z Honda, et al. Transfected platelet-activating factor receptor activates mitogen-activated protein (MAP) kinase and MAP kinase kinase in Chinese hamster ovary cells. J Biol Chem. 1994 Jan 21;269 (3) :2307-15.|[3]Muhammad S Riaz, et al. Direct Growth Inhibitory Effect of Platelet Activating Factor C-16 and Its Structural Analogs on Mycobacteria. Front Microbiol. 2018 Sep 11;9:1903.|[4]Jing Chu, et al. IGHG1 Regulates Prostate Cancer Growth via the MEK/ERK/c-Myc Pathway. Biomed Res Int. 2019 Jul 4;2019:7201562.|[5]Nina Bögershausen, et al. RAP1-mediated MEK/ERK pathway defects in Kabuki syndrome. J Clin Invest. 2015 Sep;125 (9) :3585-99.Shipping Conditions :
Blue IceStorage Conditions :
-20°C (Powder, stored under nitrogen)Scientific Category :
Reference compound1Clinical Information :
No Development ReportedIsoform :
ERK; Human Endogenous Metabolite; MEKCAS Number :
[74389-68-7]

